ABL Diagnostics
Pre-clinicalDeepChek®Genotyping through NGS & Sanger Sequencing
Founded
2000
Focus
Diagnostics
About
DeepChek®Genotyping through NGS & Sanger Sequencing
Funding History
3Total raised: $26M
Series B$15MBpifranceSep 15, 2021
Series A$5.5MUndisclosedJun 15, 2021
Series A$5.5MOmnes CapitalJun 15, 2019
Company Info
TypePrivate
Founded2000
LocationStrasbourg, France
StagePre-clinical
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Adocia
Phase 3 · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile